Understanding real‐world clinical experience with lecanemab: Capturing the patient and care partner voice through social media listening
Qualitative social media themes described lecanemab as slowing disease progression and extending patients' quality time with their loved ones. The posts report side effects which may influence beginning or continuing treatment. Although currently a small sample, social media listening may reveal considerations and opportunities to improve patient care.
Authors
- Feride Frech (ORCID: https://orcid.org/0000-0002-1992-1112)
- Amanda Blackwood
- Marc DeCongelio (ORCID: https://orcid.org/0009-0004-5486-5584)
- Craig Plauschinat (ORCID: https://orcid.org/0000-0002-8002-6838)
- Pippa Brown
- Vicky Britton (ORCID: https://orcid.org/0009-0008-1046-7129)
- Hideki Toyosaki
- Lee Watson
- Monica K Crane
- Alison Bulkley
Institutions
- Oracle (United States) (US)
- Knoxville College (US)
- Oracle (United Kingdom) (GB)
- Genesis Medical Center (US)
- Eisai (United States) (US)
- Tennessee Orthopaedic Clinics (US)
- University of Tennessee at Knoxville (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70860_102018
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00